MedTrace Logo

Face Transplantation Clinical Trial

NCT01269164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-08-31

No results posted yet for this study

Summary

The purpose of this study is to apply human facial allograft transplant to the subjects with severe facial deformities or disfigurements in order to provide adequate coverage, aesthetic appearance and functional outcome.

Conditions

  • Severe Facial Deformities

Interventions

PROCEDURE

Surgical Procedure Composite Facial Transplant

Single Center Prospective Clinical Study to Document the Safety and Feasibility of the Surgical Procedure for Composite Facial Allograft Transplantation

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Frank Papay, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2020-08-31
Completion
2020-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01269164 on ClinicalTrials.gov